Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Novartis Pharmaceuticals
Summary
The aim of this study is to assess treatment patterns, clinical outcomes, and patient characteristics among adults with metastatic castration-resistant prostate cancer (mCRPC) in the United States (US) real-world clinical practice. This study will be conducted using data extracted from the PRECISION (PRostatE Cancer dISease observatION) data platform.
Official title: Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Contemporary Patients With Metastatic Castration-Resistant Prostate Cancer in the PRECISION Data Platform
Key Details
Gender
MALE
Age Range
18 Years - 115 Years
Study Type
OBSERVATIONAL
Enrollment
17111
Start Date
2026-06-30
Completion Date
2026-11-30
Last Updated
2026-06-30
Healthy Volunteers
No